January 4, 2023

BioLineRx Appoints Tami Rachmilewitz, M.D., as Chief Medical Officer

December 20, 2022

BioLineRx Announces Results from Phase 1/2a Study of Investigational Anti-Tumor Vaccine AGI-134 in Metastatic Solid Tumors

November 28, 2022

BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event